LPA and coronary artery disorder: In this study, we have chosen a cut-off of 60 mg/dL for the highest risk group, as this is the value that is the indication for lipoprotein apheresis for elevated Lp(a) in patients with repeat CHD events despite optimal LDL-lowering therapy in Germany [19].